State of Wisconsin Investment Board’s Aclaris Therapeutics ACRS Stock Holding History

State of Wisconsin Investment Board’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-44,627	Closed	-$306K	–	2357
2023 Q3	$306K	Buy	44,627 +7,053	+19%	+$60.3K	﹤0.01%	2044
2023 Q2	$390K	Sell	37,574 -1,946	-5%	-$17.6K	﹤0.01%	1903
2023 Q1	$320K	Sell	39,520 -4,401	-10%	-$55.9K	﹤0.01%	2068
2022 Q4	$692K	Sell	43,921 -2,881	-6%	-$46.3K	﹤0.01%	1734
2022 Q3	$737K	Sell	46,802 -1,636	-3%	-$25.8K	﹤0.01%	1721
2022 Q2	$676K	Sell	48,438 -7,862	-14%	-$110K	﹤0.01%	1911
2022 Q1	$971K	Hold	56,300	–	–	﹤0.01%	1649
2021 Q4	$819K	Hold	56,300	–	–	﹤0.01%	1517
2021 Q3	$1.01M	Hold	56,300	–	–	﹤0.01%	1445
2021 Q2	$989K	Buy	+56,300	New	+$1.28M	﹤0.01%	1456
2019 Q3	–	Sell	-36,800	Closed	-$81K	–	1541
2019 Q2	$81K	Buy	36,800 +800	+2%	+$4.36K	﹤0.01%	1526
2019 Q1	$216K	Buy	36,000 +8,200	+29%	+$54.4K	﹤0.01%	1457
2018 Q4	$205K	Hold	27,800	–	–	﹤0.01%	1455
2018 Q3	$404K	Buy	27,800 +12,800	+85%	+$219K	﹤0.01%	1436
2018 Q2	$300K	Hold	15,000	–	–	﹤0.01%	1398
2018 Q1	$263K	Hold	15,000	–	–	﹤0.01%	1379
2017 Q4	$370K	Hold	15,000	–	–	﹤0.01%	1331
2017 Q3	$387K	Hold	15,000	–	–	﹤0.01%	1342
2017 Q2	$407K	Buy	+15,000	New	+$408K	﹤0.01%	1330

Other funds holding ACRS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

State of Wisconsin Investment Board's ACRS Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of Aclaris Therapeutics (ACRS) in Q4 2023, closing a stake of 44,627 shares — an estimated $306K sold.

State of Wisconsin Investment Board first reported a position in ACRS in Q2 2017 and held it in 19 quarters. The position peaked at $1.01M in Q3 2021. 107 funds tracked by Wall St. Rank hold ACRS as of Q4 2023.

State of Wisconsin Investment Board reported no remaining Aclaris Therapeutics position as of Q4 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 44,627 Aclaris Therapeutics shares in Q4 2023, an estimated $306K.
State of Wisconsin Investment Board first reported a position in Aclaris Therapeutics in Q2 2017 and held it in 19 quarters.
State of Wisconsin Investment Board's Aclaris Therapeutics position peaked at $1.01M in Q3 2021.
107 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.